Kovitz Investment Group Partners, LLC Uro Gen Pharma Ltd. Transaction History
Kovitz Investment Group Partners, LLC
- $23.6 Billion
- Q3 2025
A detailed history of Kovitz Investment Group Partners, LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Kovitz Investment Group Partners, LLC holds 34,802 shares of URGN stock, worth $846,732. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,802
Previous 34,802
-0.0%
Holding current value
$846,732
Previous $476,000
42.65%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding URGN
# of Institutions
171Shares Held
44.1MCall Options Held
1.61MPut Options Held
433K-
Rtw Investments, LP New York, NY4.54MShares$111 Million1.19% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.22MShares$103 Million2.65% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A63.19MShares$77.6 Million0.1% of portfolio
-
Morgan Stanley New York, NY2.53MShares$61.5 Million0.0% of portfolio
-
Jefferies Financial Group Inc. New York, NY2.2MShares$53.5 Million0.21% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $553M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...